All Professionals
Overview
Kamilah Alexander is an associate in the Intellectual Property Litigation practice of Paul Hastings and is based in the firm's San Diego office. Her practice focuses on all aspects of pharmaceutical, biotechnology, and medical technology patent litigation. She has litigated matters in district court, at the Patent Trial and Appeal Board, at the International Trade Commission, and in arbitration.
Education
- New York University School of Law, J.D., 2015
- Harvard University, Ph.D., 2001
- Massachusetts Institute of Technology, B.S., 1996
Representations
- Secured a complete victory for ResMed Inc. in seven IPRs of patents being asserted against the company in district court. The Board invalidated every instituted claim of the seven patents.
- Represented Par Pharmaceuticals in a Paragraph IV patent infringement suit for its epinephrine injection drug, Adrenaline. The District Court upheld the validity of the formulation and method of treatment patents and found them infringed.
- Represented AbbVie Inc. in several BPCIA litigations involving its top-selling monoclonal antibody Humira (adalimumab) against several major pharmaceutical companies intending to manufacture adalimumab biosimilars. All litigations were favorably settled.
- Represented Eagle Pharmaceuticals in a patent infringement suit involving Bendeka (bendamustine). The litigation was favorably settled before trial.
- Prepared an innovator pharmaceutical company for Paragraph IV patent litigation against thirteen potential generic ANDA filers.